Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study-Reference-Cited by-同舟云学术

Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study

Published:2013-01-24 Issue:5 Volume:120 Page:568-575
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Bernard N¹,Elefant E²,Carlier P³,Tebacher M⁴,Barjhoux CE⁵,Bos-Thompson MA⁶,Amar E⁷,Descotes J¹,Vial T¹

Affiliation:

1. Centre Régional de Pharmacovigilance; Hospices Civils de Lyon; Lyon; France

2. Centre de Référence sur les Agents Tératogènes; Hôpital Trousseau; Paris; France

3. Centre Régional de Pharmacovigilance; Hôpital Fernand Widal; Paris; France

4. Centre Régional de Pharmacovigilance; Hôpital Civil; Strasbourg; France

5. Centre Régional de Pharmacovigilance; Centre Hospitalo-Universitaire; Grenoble; France

6. Centre Régional de Pharmacovigilance; Hôpital Lapeyronie; Montpellier; France

7. Registre des malformations en Rhône-Alpes; Lyon; France

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Reference21 articles.

1. Pharmacological properties of mifepristone: toxicology and safety in animal and human studies;Sitruk-Ware;Contraception,2003

2. Haute Autorité de Santé Recommandations de bonne pratique. Interruption volontaire de grossesse par méthode médicamenteuse www.has-sante.fr/portail/jcms/c_961137/interruption-volontaire-de-grossesse-par-methode-medicamenteuse

3. Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy;Lièvre;Contraception,2009

4. Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis;Silva dal Pizzol;Reprod Toxicol,2006

5. Fetal malformation and failed medical termination of pregnancy;Sitruk-Ware;Lancet,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal methods for emergency contraception;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-12

2. Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review;Clinical Pharmacology & Therapeutics;2024-07-25

3. Risk of teratogenicity in continued pregnancy after gestational exposure to mifepristone and/or misoprostol: a systematic review and meta-analysis;Archives of Gynecology and Obstetrics;2024-07-09

4. Mice born preterm develop gait dystonia and reduced cortical parvalbumin immunoreactivity;2024-02-02

5. Post-abortion Care;Textbook of Contraception, Sexual and Reproductive Health;2024-01-25